Agilent Technologies and Groton Biosystems sign agreement
Agilent Technologies Inc. (Santa Barbara, California) and Groton Biosystems LLC (Boxborough, Massachusetts) recently announced an agreement.
Agilent Technologies Inc. (Santa Barbara, California) and Groton Biosystems LLC (Boxborough, Massachusetts) recently announced an agreement to co-market solutions for the Process Analytical Technology (PAT) Initiative for the pharmaceutical industry in the United States and Canada.
PAT is a system for designing, analyzing, and controlling manufacturing by measuring critical quality and performance attributes of raw and in-process materials and processes with the goal of ensuring final product quality.
The alliance is designed to benefit biopharmaceutical customers who perform in-process and final product testing in a wide range of production segments.The agreement, expected to expand to Europe and Asia in the near future, brings together Agilent's HPLC systems with Groton Biosystems' strong online sampling products and services.
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.
